GATE 2013

Official Notification for GATE 2013

 Apply online from 01-09-2012.

 BIOTECHNOLOGY (BT) and LIFE SCIENCES (XL) Online Exam from This Time

No application fee for female applicants.

Graduate Aptitude Test in Engineering (GATE) is an all India examination that primarily tests the comprehensive understanding of various undergraduate subjects in Engineering and Technology.  GATE is conducted jointly by the Indian Institute of Science and seven IITs (IIT Bombay, IIT Delhi, IIT Guwahati, IIT Kanpur, IIT Kharagpur, IIT Madras and IIT Roorkee) on behalf of the National Coordination Board – GATE, Department of Higher Education, Ministry of Human Resource Development (MHRD), Government of India. The GATE score of a candidate reflects the relative performance level of a candidate. The score is used for admissions to various post-graduate programmes (eg. M.E., M.Tech, direct Ph.D.) in Indian higher education institutes with financial assistance provided by MHRD and other Government agencies.  The score may also be used by Public sector units for employment screening purposes.  

Dates of Examination
Online: 20th  January 2013 (Sunday)
Offline: 10th  February 2013 (Sunday)

What’s New in GATE 2013?

1. 15 subject papers will be conducted by an ONLINE computer based test: AE, AG, AR, BT, CE, CH, CY, GG, MA, MN, MT, PH, TF, XE, and XL.
2. Female candidates  are exempted from paying the application fee.
3. All candidate related information and grievance redressal will be available in a single GATE Online Applicant Interface. 
4. Soft copies of photograph and signature must be uploaded during online application (This is in addition to sending recent photograph of applicant with signed application).
5. A new formula will be used for calculating the GATE score.
6. Biometric information (Photograph and fingerprint) may be captured on the day of the examination for randomly selected candidates.

Important Points for GATE 2013.

1. Application Process: For GATE 2013,  candidates need to register and fill the application ONLINE only by accessing the zonal GATE websites of IISc and seven IITs. The application process is complete only when a print out of the filled ONLINE application with the candidate’s signature and a good quality photo affixed in the appropriate place is received by the respective GATE office along with necessary documents, if any, on or before 8 October 2012. Please note that application forms are NOT available for sale anywhere.
2. Downloadable Admit Card: Admit cards are NOT sent by mail anymore. Admit cards can only be downloaded from the zonal GATE websites from 5th December 2012 onwards. Bring the admit card to the test center along with at least one original (not photocopied / scanned copy) and valid (not expired) photo identification.
3. Use of black ink ball point pen for Offline exams:  Candidates should use only black ink ball point pen for darkening of the bubbles in the OMR sheet. Since bubbles darkened by the black ink ball point pen cannot be erased, candidates should darken the bubbles in the OMR sheet very carefully (be sure before darkening).
4. Numerical answer type questions in ONLINE papers: In the ONLINE papers, the question paper will consist of questions of multiple choice type and questions of numerical answer type. For multiple choice type questions, each question will have four choices for the answer. For numerical answer type questions, each question will have a number as the answer. Each online paper will have 15 or more marks worth of questions requiring numerical answers where possible.
5. Pre-final year students:  Pre-final year students are NOT eligible to write GATE 2013. For details, refer to eligibility for GATE examination.

Important Dates

GATE Online Applicant Interface (website) Opens	Saturday	1 September 2012 (00:00 Hrs)
Last date for Submission of Online Application (website closure)	Sunday	30 September 2012 (23:00 Hrs)
Last date for the receipt of printed version of ONLINE Application at the respective zonal GATE Office	Monday	8 October 2012
Last date for request of change of city	Tuesday	20 November 2012
Availability of admit card on Online Application Interface	Wednesday	5 December, 2012
GATE 2013 Online Examination for Papers: AR, CE, GG, MA, MT, PH and TF	Sunday	20 January 2013 (09:00 Hrs to 12:00 Hrs)
GATE 2013 Online Examination for Papers: AE, AG, BT, CH, CY, MN, XE and XL	Sunday	20 January 2013 (14:00 Hrs to 17:00 Hrs)
GATE 2013 Offline Examination for Papers: CS, ME and PI	Sunday	10 February 2013 (09:00 Hrs to 12:00 Hrs)
GATE 2013 Offline Examination for Papers: EC, EE and IN	Sunday	10 February 2013 (14:00 Hrs to 17:00 Hrs)
Announcement of results on Online Applicant Interface	Friday	15 March 2013 (10:00 Hrs)

Eligibility 
The following categories of candidates are  eligible to appear in GATE:

• Bachelor’s degree holders in Engineering/ Technology/ Architecture (4 years after 10+2/ Post-B.Sc./ Post-Diploma) and those who are in the final year of such programs.
• Master’s degree holders in any branch of Science/ Mathematics/ Statistics/ Computer Applications or equivalent and those who are in the final year of such programs.
• Candidates in the second or higher year of Four-year integrated Master’s degree programs (Post-B.Sc.) in Engineering /Technology.
• Candidates in the fourth or higher year of Five-year integrated Master’s degree programs or Dual Degree programs in Engineering/Technology.
• Candidates with qualifications obtained through examinations conducted by professional societies recognized by uPSC/AiCTE (e.g. AMiE by iE(i), AMiCE(i) by the institute of CivilEngineers (india)-iCE(i)) as equivalent to B.E./B.Tech. Those who have completed section A or equivalent of such professional courses are also eligible.
• Application Deadlines
  commencement of online application:1stSeptember 2012 (Saturday)
  last date for Submission of online application (website closure):
  30th September 2012 (Sunday)
  Receipt of application with supporting documents at GATE offices:
  8th October 2012 (Monday)
  Application Fee
  • 1200 for General/OBC male applicants and
  • 600 for SC/ST/PD male applicants.
  • There is no application fee for female applicants.
  • The application fee is not refundable.
  How to Apply 
  Application must be done Online. Further details and Online application form can be obtained by accessing any of the websites given below :
  • iisc Bangalore : gate.iisc.ernet.in
  • iit Bombay : www.gate.iitb.ac.in 
  • iit delhi : gate.iitd.ac.in 
  • iit Guwahati : www.iitg.ernet.in/gate
  • iit Kanpur : gate.iitk.ac.in
  • iit Kharagpur : gate.iitkgp.ac.in
  • iit madras : gate.iitm.ac.in
  • iit roorkee : www.iitr.ernet.in/gate 

Conspiracy Theories And Believing The Impossible

This is  an article which  i have  found very interesting.
Citation: Michael J. Wood, Karen M. Douglas, and Robbie M. Sutton, 'Dead and Alive: Beliefs in Contradictory Conspiracy Theories', Social Psychological and Personality Science, 1948550611434786, first published on January 25, 2012 doi: 10.1177/1948550611434786
Main Source: www.science20.com.
Distrust and paranoia did not start with claims about genetically modified foods or vaccines. Concern about the motivations of government, secret societies and corporations has a long history. The belief in a conspiracy of elites fuels suspicion about all authorities and the claims they make. 

What is more of a puzzle is that the attraction of conspiracy theories is so strong that it leads people to endorse entirely contradictory beliefs, like how the government should make special regulations for genetically modified foods, though the government is supposedly dependent on lobbyist money and can't be trusted.

People who endorse conspiracy theories see authorities as fundamentally deceptive, they may just see it about different groups. Regardless, the conviction that the "official story" is untrue, be it about 9/11 or the Kennedy assassination or food, can lead people to believe several alternative theories-despite contradictions among them. 

"Any conspiracy theory that stands in opposition to the official narrative will gain some degree of endorsement from someone who holds a conpiracist worldview," according to Michael Wood, Karen Douglas and Robbie Sutton of the University of Kent, who co-authored an article on the willing contradictions of conspiracy believers.

To see if conspiracy views were strong enough to lead to inconsistencies, the researchers asked 137 college students about the death of Princess Diana. The more people thought there "was an official campaign by the intelligence service to assassinate Diana," the more they also believed that "Diana faked her own death to retreat into isolation." 

How could they believe both?  She was a British woman, not an Austrian physicist's cat.   She can't be simultaneously dead and alive.

The researchers wanted to know if the contradictory beliefs were due to suspicion of authorities, so they asked 102 college students about the death of Osama bin Laden (OBL). People who believed that "when the raid took place, OBL was already dead," were significantly more likely to also believethat "OBL is still alive." 

Since bin Laden is no more Schrödinger's cat than Diana was, he must be alive or dead. The researchers found that the belief that the "actions of the Obama administration indicate that they are hiding some important or damaging piece of information about the raid" was responsible for the connection between the two conspiracy theories. Conspiracy belief is so potent that it will lead to belief in completely inconsistent ideas.

"For conspiracy theorists, those in power are seen as deceptive-even malevolent-and so any official explanation is at a disadvantage, and any alternative explanation is more credible from the start," said the authors. 

It is no surprise that fear, mistrust, and even paranoia can lead to muddled thinking; when distrust is engaged, careful reasoning can coast on by. 

"Believing Osama is still alive," they write, 'is no obstacle to believing that he has been dead for years."

Or that scientists are out to save us regarding global warming and out to kill us about food

JRF post in ICGEB, New Delhi

JRF for antimalarial drug Discovery Project on “Discovering Antimalarials
from Marine Organisms (phase III): Bulk Recollection of Promising Marine
Organisms-Isolation, Purification, Characterization and Chemical Synthesis
of Marine derived Antimalarials”
This  multi institutional  DBT project will use state of the art activity guided HPLC
purification of antiplasmodial molecules derived from extracts of marine organisms.
Screening of extracts and purified molecules will be done in microtiter plate format by
ex vivo culture of Plasmodium falciparum strains in human red blood cells and inhibition
of growth of malaria parasite will be monitored by SYBR Green based Fluorescence
screen. Selectivity Indices will be determined by comparing IC50 (Mammalian cell)/IC50
(P.falciparum). Only those with good credentials in chromatography, Spectroscopy,
Molecular Biology, Cell biology, diligent habits of experiment documentation and
aptitude for drug discovery need apply within six weeks to:
Dr Dinkar Sahal, 
Malaria Research Laboratory,
International Centre for Genetic Engineering and Biotechnology,
 New Delhi 110 067.
dinkar@icgeb.res.in
Notification date :13th August 2012

Technical Assistant post in University of Hyderabad

 

Applications are invited from the eligible candidates (Indian Nationals only) on a plain paper for the following temporary post in the research project entitled “Understanding Genome Organization and Gene Expression in Response to different Hexachlorocyclohexane (HCH) Isomers in HCH Degrading Bacteria and the HCH Dumpsite” sponsored by Department of Biotechnology, New Delhi. Technical Assisstant No. of posts: 1 Salary p.m (Rs.): 12000/- (fixed) Tenure: 3 years Requirement for the post (Qualification, age limit, NET exam, experience etc., as per guidelines): Graduate/Post graduate in any branch of Life Sciences + 5 years experience in relevant field Applicants should note that the appointments to be made are purely temporary and there is no right for claiming for any regular appointment in the University. No TA/DA will be paid for attending the interview or at the time of joining the post. The application should be submitted in the enclosed format which must be accompanied by attested copies of certificates in support of all information furnished in the application. Last date for receipt of filled in application: 28-08-2012. Applications should be sent to the below mentioned address. Prof. S. Dayananda, Dept. of Animal Sciences, School of Life Sciences, University of Hyderabad, Hyderabad- 500046. University of Hyderabad

How many of you know about BIOCARe DBT for Women

THE Department of Biotechnology Government of India Announces The Call For Proposals Under “ Biotechnology Career Advancement and Re-Orientation Programme For Women Scientists’

Conducted by: Department of Biotechnology

Programme: Biotechnology Career Advancement and Re-orientation Programme for Women Scientists

Eligibility:

• M.D/M. Tech /Ph. D/Equivalent degree in any branch of Life Sciences
• Women Scientists who are employed or unemployed or are coming back after a break.
• Women Scientists for whom it is the first grant.  (Women Scientist who have already availed any grant as PI from Government Funding Agency under WOS (A&B) of DST are not eligible to apply).
• Women Scientists upto 55 years of age
• The scheme is open to women applicants from all areas in  Life Science or biology (including agriculture, veterinary science and medicine)

Budget/Stipend:  There would be a provision for stipend fellowship amount as lumpsum in the following 3 slabs for the unemployed candidate in the budgets provision.  The slabs would be decided based on post Ph.D experience

• Grade – I   Rs.35, 000/- (Ph.D+ nil experience)
• Grade – II Rs.40,000/-(Ph.D + more than 5 years research/industrial experience)
• Grade– III Rs.45,000/-(Ph.D+ more than 10 years research/industrial experience)

Selection process:

• The candidate will have to provide proof of year of experience.
• If a selected candidate is availing a Post-Doctoral or Contractual fellowship she will have to resign from the same before accepting the project under Bio-CARe programme.

Benefits:

• For employed candidate an additional amount of Rs. 5,000/- over her salary would be provided as an incentive
• The total budget for R&D project will range from 25 lakhs to 50 lakhs. All research related expenses to be booked under Equipment, Consumables, Manpower, Contingency, Travel etc as in other ongoing R&D Schemes.                 Application Procedure will be starting from the month of April every year and has a dead line in may.
• For more details   http://dbtindia.nic.in.

• To facilitate the participation of Women Scientists in Biotechnology Research, DBT announces the launch of Bio-CARe Scheme for Career Development of employed/unemployed women scientists who have not received any extra-mural grants in the past. In order to maximize their reach, the schemes are open to applicants (aged 55 years or less on the date of application) from all areas of Life Sciences / biology (including Agriculture, Veterinary Science, Medicine and Bio-Engineering).
  
  
                Scheme I – Research Grant Opportunity (RGO):
  The programme aims at giving project grants to women scientists (employed & unemployed) for whom it would be a first grant. The purpose is to build capacities for women scientists employed fulltime in Universities and small research laboratories or unemployed women scientist after a career break so as to help them undertake independent R&D projects. Under this scheme the women scientists who are unemployed will be provided monthly emoluments ranging from Rs. 35,000/- to 45,000/- p.m. The employed women scientists in addition to salary will get an amount of Rs.5,000/- p.m as an incentive.
  
  
  
  
  
  
    Scheme II -Career Re-orientation Fellowship (CRF):
  This scheme would be mainly for women scientists who are trained in a particular area, but leave their permanent jobs / or are unemployed and would now like to change their career path to take on newer areas. Specialized skills would be essential and this would require training in the relevant field such as IP management, Bioinformatics, Policy research and analysis, Translational research, Regulation etc. This training could be for a period ranging from 3 months -12 months. Under this scheme the women scientists who are unemployed will be provided a stipend of Rs.25,000/- p.m. and employed scientists will get an amount of Rs.5,000/- p.m as an incentive in addition to their salary. 

Did you know about Anti HIV protein?

Researchers have synthesized a protein that jams the "grappling hook" that HIV uses to attach to target cells. The synthetic protein prevents a spring-loaded component of the grappling hook from snapping shut and drawing the virus to its target—one of the key steps in HIV infection. If HIV cannot fuse with the membrane on its target cell, infection cannot occur.

The researchers believe that the new protein may be useful in treating patients with drug-resistant HIV or those patients who experience side effects when taking antiviral medications. Howard Hughes Medical Institute (HHMI) investigator Peter S. Kim and his colleagues at the Whitehead Institute for Biomedical Research at MIT reported on the new anti-HIV protein in a research article published online on January 12, 2001, by the journalScience .

Development of the HIV-inhibiting protein, called 5-Helix, is based on earlier studies that showed that HIV uses a spring-loaded mechanism to attach to T cells, its primary targets in the immune system. In attaching to T cells, HIV first uses a protein called gp120 to recognize the CD4 receptor on the surface of a T cell. Once gp120 recognizes CD4, an HIV attachment protein called gp41 launches a harpoon-like component into the T cell’s membrane. Next, gp41’s spring mechanism snaps shut—forming what is known as the "trimer of hairpins," (named for its triple helical, u-shaped protein structure)—and draws the virus to the T cell like a grappling hook. The virus can then fuse its membrane with the T cell’s membrane.

In previous studies, a research team led by Kim and a second that included HHMI investigators Stephen C Harrison and Don Wiley at Harvard independently solved the structure of gp41. Kim's group focused on deep pockets in the molecule that looked to be excellent targets for inhibitory molecules. Last year, Kim's team identified D-peptide inhibitors of HIV infection that bound solely to the pocket, laying the groundwork for the potential development of "orally bioavailable inhibitors of HIV entry," said Kim. In addition, Harrison and HHMI investigator Stuart L. Schreiber created a library of compounds that fit into the pocket, when attached to a longer peptide, to block the action of gp41.

Other research on gp41 inhibitors has also shown that synthetic peptides could be created to bind to the grappling hook end of gp41 nearest the target cell—called the N-terminal end. In fact, such peptides have proven to be potent inhibitors of HIV, and one is currently in clinical trials.

Kim and his colleagues wanted to test the idea that protein inhibitors that bind to the C-terminal end of gp41—the end nearest the virus—could also be potent inhibitors of HIV infection by stopping the closing of the trimer-of-hairpins. To test this hypothesis, they synthesized 5-Helix, a small protein designed to bind to the C-terminal region, and looked at whether it could jam gp41 in cell culture.

"We really didn't know whether binding to the C-terminal region would actually stop the virus," said Kim. "So, we were pleasantly surprised to find that not only did it inhibit the virus, but it did so quite effectively. What’s more, we were very pleased to find that 5-Helix was capable of inhibiting a wide range of HIV isolates."

Analyzing the structure of the C-terminal region of gp41 in many versions of HIV, Kim and his colleagues found that, although there is variability in the region, the "face" of the C-terminal helix that actually interacts with 5-Helix is highly conserved among the different viral strains.

According to Kim, the 5-Helix molecule is stable, and is therefore likely to be resistant to degradation by the body’s enzymes. This is one reason why Kim believes that 5-Helix may be a good candidate for becoming an injectable anti-HIV therapy. Also, he said, the molecule can be altered—for instance, making it larger to reduce its elimination in the kidneys—without diminishing its ability to jam gp41. And carbohydrate molecules could also be added to the molecule to help shield it from the immune system, he added.

Kim foresees 5-Helix or its molecular cousins proving to be effective as "salvage therapies" to treat HIV patients who are suffering side effects from other drugs, or in whom HIV has mutated to become drug resistant. The durability of 5-Helix and its effectiveness bode well for rapid progress toward a therapy, he said.

"I think we are only a few steps away from testing in monkeys—for which good models of HIV infection exist—to determine whether 5-Helix or a derivative can reduce the viral load in the bloodstream," Kim said.

Other clinically important viruses also use similar trimer-of-hairpins proteins in infection, and a similar approach to inhibiting attachment might also work against them. "Work from our lab and from Don Wiley's lab has shown that the influenza and Ebola viruses use a similar mechanism, and we have recently shown that the human respiratory syncytial virus also uses the trimer-of-hairpins motif. All of these viruses are significant threats to human health, and we are hopeful that our approach to HIV inhibition can be broadly effective against them as well," said Kim.

I will be soon updating about the latest information

Quality Control post in Dr. Reddy's Laboratories, Hyderabad

Established in 1984,  Dr. Reddy's LaboratoriesLtd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and News Chemical Entities (NCEs).

Job Description 
1. Sound knowledge in proteins therapeutics 2. cGMP awareness 3. Perform HPLC assays for commercial and stability samples as per the set plan 4. Report writing, document revisions 5. Involve in discrepancy and investigations 6. Perform method validations and involve in technology transfers 7. Prepare product trends 

Salary:
Not Disclosed by Recruiter 

Industry:
Pharma, Biotechnology, Clinical Research 

Functional Area:
Production, Manufacturing, Maintenance 

Role Category:
Production/ Manufacturing/ Maintenance 

Role:
Quality Assurance/ Quality Control Executive 

Keyskills:
proteins therapeutics , cGMP , Good communication , good team player 

Desired Candidate Profile 

Education:
(UG - B.Sc - Any Specialization) AND (PG - M.Sc - Bio-Chemistry, Microbiology) 

Contact Details 

Contact Company: Dr Reddys Laboratories Ltd 

Address:
8-2-337, Road No 3, Banjara Hills HYDERABAD,Andhra Pradesh,India 500034 
http://www.drreddys.com  

Unlocked: The link between sex and the female brain

An international team of scientists led by Gregg Adams at the University of Saskatchewan has discovered that a protein in semen acts on the female brain to prompt ovulation, and is the same molecule that regulates the growth, maintenance, and survival of nerve cells.

Male mammals have accessory sex glands that contribute seminal fluid to semen, but the role of this fluid and the glands that produce it are not well understood.

"From the results of our research, we now know that these glands produce large amounts of a protein that has a direct effect on the female," says Adams, a professor of veterinary biomedical sciences at the Western College of Veterinary Medicine at the U of S.

The work, which appears in the August 20, 2012 issue of the Proceedings of the National Academy of Sciences (PNAS), raises intriguing questions about fertility in mammals, including humans.

The team characterized the protein, dubbed ovulation-inducing factor (OIF), that they have found in the semen of all species of mammal they have looked at so far. In the process of discovering its identity, the team compared OIF to thousands of other proteins, including nerve growth factor (NGF) which is found primarily in nerve cells throughout the body.

"To our surprise, it turns out they are the same molecule," Adams says. "Even more surprising is that the effects of NGF in the female were not recognized earlier, since it's so abundant in seminal plasma."

While OIF/NGF may function differently from animal to animal, it is present in all mammals studied so far, from llamas, cattle and koalas to pigs, rabbits, mice, and humans. This implies an important role in reproduction in all mammals. Just how it works, its role in various species, and its clinical relevance to human infertility are a few of the questions that remain to be answered.

OIF/NGF in the semen acts as a hormonal signal, working through the hypothalamus of the female brain and the pituitary gland. This triggers the release of other hormones that signal the ovaries to release an egg (or eggs, depending on the species).

For this latest study, the team looked at two species: llamas and cattle. Llamas are "induced ovulators," that is, they ovulate only when they have been inseminated. Cows – and humans – are "spontaneous ovulators," meaning that a regular buildup of hormones stimulates the release of an egg.

Using a variety of techniques, the researchers compared OIF and NGF and found them to have the same size and to cause the same effects across species. Work at the Canadian Light Source synchrotron at the U of S confirmed the structure of the molecule.

"The idea that a substance in mammalian semen has a direct effect on the female brain is a new one," Adams explains. "This latest finding broadens our understanding of the mechanisms that regulate ovulation and raises some intriguing questions about fertility."

These are crystals of pure OIF used at Canadian Light Source protein crystallography beam line.

Left to right shows Roger Pierson, Gregg Adams and Karin van Straaten with a few of the University of Saskatchewan llamas east of Saskatoon, Saskatchewan, Canada

Sexless reproduction for humans soon ?

An Indian-origin research geneticist who pioneered a celebratory work on eccentric creatures capable of reproducing without sexual contact has claimed that humans too are on the course for sexless reproduction in future.

Aarathi Prasad from Imperial College London suggests that humans could well be looking at a future where babies are born without any sperm donors, let alone contact between the sexes.
Merely a generation ago, test-tube babies were the stuff of science fiction but now they have been accepted as a reality.
Her book Like A Virgin explores a fundamentally serious theme we human beings are in control of our own destiny and there is nothing sacred or special about life itself.
This is so because we live in a world where science means we can manipulate everything — even the process of reproduction, the Daily Mail reported.
The central tenet of Aarathi’s story is that virgin births are now almost within the grasp of science.
An artificial womb — a plastic container specially designed to hold fluids and bacteria found in natural wombs, has already been pioneered in Australia.
According to Aarathi, it will one day be technically possible for a man to develop a child in one of these “wombs” without the co-operation of any female partner.
Aarathi points out that science has already developed artificial sperm.
And that such sperm has produced offspring. How far behind can be the synthetic egg? Her book also comes up with all kinds of interesting case histories which appear to suggest that a virgin birth might not be beyond the bounds of science as new techniques develop.

WALK-IN-INTERVIEWS in CRRI for technical assistant posts

CENTRAL RICE RESEARCH INSTITUTE

 Information about following will be available in http://crri.nic.in/walk_in_TH_aug12.pdf
Name of the Scheme :
No. of the  position
 Rate of   Remuneration
 Requisite qualification
Maximum  age as on 01.07.2012
Duration
Date & Time of   Interview
  Place of    posting


Terms & Conditions:
1. The above position is purely temporary and is co-terminus with the scheme/project. The services of appointed candidates will stand terminated automatically after expiry
of the scheme/project or completion of period indicated in the selection offer, whichever is  earlier and the candidate will not have any right for absorption in
CRRI/ICAR. The above age limits are relaxable for SC, ST and OBC candidates as per Govt. of India norms.
2. Eligible candidates desirous to be considered for the above-mentioned position are advised to bring one copy of their bio-data  along with Xerox copy of all the
certificates and mark sheets affixing recent photograph thereon together with original copies of educational certificate/mark sheet (matriculation onwards) and appear for
a walk-in-interview comprising of a written-cum-personal interview on prescribed date, time and place.
3. Director, CRRI reserves the right to increase/decrease the number of position and also to cancel the recruitment process for the position mentioned above.
Director's decision will be final and binding in all aspects.
4. No T A and DA for appearing in the interview are admissible.
5. Canvassing in any form will render the candidate disqualified for the position.

 

JRF post in CRIDA

F.No.DBT (SKY)/Recruit/2012 Central Research Institute for Dryland Agriculture (CRIDA), invites applications for the post of Junior Research Fellow Qualifications : First Class M.Sc (Agriculture) with specialization in biotechnology/ biochemistry/ Plant physiology/Environmental science focussing crop biotechnology/transgenics or First Class M.Sc. degree in biotechnology/ biochemistry/ Plant physiology/ Environmental science. Valid GATE/NET qualification/score is a must for Postgraduates in Science.  Desirable: Working knowledge of advanced techniques used in molecular characterization of transgenics and segregation analysis. Working knowledge in computer skills and report writing No. of Post: 1 Age:35 years  Salary : Rs. 12000/- How to apply  Walk-in-Interview is scheduled for 29th August, 2012 at 10.30 AM at Director, Central Research Institute for Dryland Agriculture, Santoshnagar Colony, Saidabad Post, Hyderabad - 500 059. Candidates should bring their duly filled application as per the format enclosed along with attested photocopy as well as original of the relevant documents and NET/GATE qualification if any.

Lab Assistant Post in University of Hyderabad -

No. of Post : One. Salary : Rs 8,000/- pm Qualifications: Intermediate with preferably Science background. Minimum three years experience of working in biology lab. Knowledge of computer based software operation such as Excel and Word for accounting and familiarity with purchase procedure is desirable. The application without experience certificates would be rejected. Send your Application to The Prof. R.P. Sharma, Dept. of Plant Sciences, School of Life Sciences, University of Hyderabad, Hyderabad- 500 046 on or before August 16th, 2012. For more information visit to http://www.uohyd.ac.in/images/recruitment/labassitant2012.pdf Last Apply Date: 16 Aug 2012 Salary : Rs 8,000/- pm Address: Prof. R.P. Sharma, Dept. of Plant Sciences, School of Life Sciences,  University of Hyderabad,  Hyderabad- 500 046

Research Associate post in ANGRAU - Hyderabad

Acharya N. G. Ranga Agricultural University, conducts walk-in-interview for the post of Research Associate .  Project Title : Development of micronutrient enriched maize through molecular Breeding-Phase II. Qualifications : Ph. D. in Plant Molecular Biology and Biotechnology or its equivalence M.Sc. (Ag.) / M.Sc. Biotechnology with three years of relevant experience  Funding Source : Department of Biotechnology, New Delhi  Age Limit : 35 Years  Pay : Rs. 22000/- Acharya N. G. Ranga Agricultural University, conducts walk-in-interview for the post of Research Associate How to apply  Walk-In-Interview will be held on 21 .08.2012 on 10.00 A.M. at Institute of Biotechnology, ANGRAU, Rajendranagar. Interested candidates are requested to appear for interview along with C.V., original certificates, experience certificates, testimonials and proof of additional credentials.